(Q52698265)

5 May 2018

title

Design of phase I and II clinical trials in cancer: a statistician's view. (English)

1 reference

5 May 2018

main subject

phase I clinical trial

0 references

author name string

Geller NL

series ordinal

1

1 reference

5 May 2018

publication date

1 January 1984

1 reference

5 May 2018

published in

Cancer Investigation

1 reference

5 May 2018

volume

2

1 reference

5 May 2018

issue

6

1 reference

5 May 2018

page(s)

483-491

1 reference

5 May 2018

Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

Management of trials in the development of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

Bioavailability--a problem in equivalence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

Interim analyses for randomized clinical trials: the group sequential approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

A Multiple Testing Procedure for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

Group sequential clinical trials with triangular continuation regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908409048522

10.3109/07357908409048522

21 January 2018

Identifiers

DOI

1 reference

5 May 2018

1 reference

5 May 2018